Comparison of before and after treatment in all measurement parameters
| Variables | Before Treatment | After Treatment | z | p |
|---|---|---|---|---|
| Mean ± SD (min–max) | Mean ± SD (min–max) | |||
| Number of tender points | 12.10±1.24 (10–15) | 7.31±2.26 (2–11) | -3.840 | 0.000** |
| VAS at night | 6.84±1.30 (3–9) | 0.91±0.64 (0–2) | -3.843 | 0.000** |
| VAS in activity | 7.31±1.24 (4–9) | 1.11±0.81 (0–2.20) | -3.850 | 0.000** |
| VAS in rest | 6.42±1.46 (3–9) | 0.49±0.81 (0–2.40) | -3.834 | 0.000** |
| Distance of Tragus-Wall (cm) | 12.08±1.95 (9–17) | 10.72±1.90 (8.20–15.60) | -3.529 | 0.000** |
| Distance of processus spinosus-Skapula (cm) (R) | 10.65±3.03 (6.50–17) | 10.26±2.76 (7–15) | -2.007 | 0.045* |
| Distance of processus spinosus-Skapula (cm) (L) | 11.21±3.17 (7–17) | 10.26±2.76 (7–15) | -2.842 | 0.004** |
| Trunk Lateral Flexion (°) (R) | 36.47±3.35 (30–41) | 37.00±3.39 (30–41) | -1.821 | 0.069 |
| Trunk Lateral Flexion (°) (L) | 33.47±4.01 (27–41) | 36.68±3.28 (30–41) | -3.534 | 0.000** |
| Distance of hand-floor (cm) | 6.86±4.84 (0–17) | 5.18±3.92 (0–14) | -3.219 | 0.001** |
| FIQ | 56.25±18.74 (19.79–85.58) | 46.39±17.99 (19.59–67.98) | -3.724 | 0.000** |
| HAD-A | 10.89±3.91 (5–19) | 4.73±3.49 (0–10) | -3.849 | 0.000** |
| HAD-D | 9.78±3.29 (2–15) | 5.05±2.06 (0–9) | -3.632 | 0.000** |
| PSQI | 10.52±3.40 (5–15) | 3.63±2.47 (0–8) | -3.830 | 0.000** |
Wilcoxon Test. *p<0.05; **p<0.001.VAS: Visual Analog Scale;FIQ: Fibromyalgia Impact Questionnaire; HAD-A: Hospital Anxiety and Depression-Anxiety; HAD-D: Hospital Anxiety and Depression-Depression; PSQI: Pittsburgh Quality of Sleep Questionnaire Index.